Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) EBITDA Margin (2021 - 2025)

Historic EBITDA Margin for Pulse Biosciences (PLSE) over the last 3 years, with Q3 2025 value amounting to 22540.7%.

  • Pulse Biosciences' EBITDA Margin changed N/A to 22540.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 86898.84%, marking a year-over-year change of. This contributed to the annual value of 8357.86% for FY2022, which is 38685100.0% down from last year.
  • Pulse Biosciences' EBITDA Margin amounted to 22540.7% in Q3 2025.
  • In the past 5 years, Pulse Biosciences' EBITDA Margin ranged from a high of 102188.89% in Q4 2022 and a low of 22540.7% during Q3 2025
  • Moreover, its 3-year median value for EBITDA Margin was 2157.35% (2021), whereas its average is 10761.35%.
  • The largest annual percentage gain for Pulse Biosciences' EBITDA Margin in the last 5 years was 1040154300bps (2022), contrasted with its biggest fall of -202394400bps (2022).
  • Over the past 3 years, Pulse Biosciences' EBITDA Margin (Quarter) stood at 1826.54% in 2021, then surged by 5695bps to 102188.89% in 2022, then tumbled by -122bps to 22540.7% in 2025.
  • Its last three reported values are 22540.7% in Q3 2025, 102188.89% for Q4 2022, and 4665.33% during Q2 2022.